SecBot SecBot
COURT-RULING ·Filed Jul 23, 2026

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD
NEUTRAL
Impact 2/10
Horizonmonths Processed3mo ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight • Neutral

This is a routine procedural loss with no material impact on Teva's stock. The underlying antitrust case continues, monitor for summary judgment motions or trial dates, which would be the next material catalysts.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$30.81
T+0 close · Jul 24, 2026 · via day close
Latest settled
+34.08%
T+60 · $41.31
Vs SPY
+30.09%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 24 $30.81entry
  2. T+1 · 4mo ago +0.88%α +0.85% · $31.08
  3. T+5 · 4mo ago +13.63%α +12.54% · $35.01
  4. T+20 · 3mo ago +21.19%α +17.57% · $37.34
  5. T+60 · 29d ago +34.08%α +30.09% · $41.31
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Teva lost a discovery dispute in its antitrust/physician-payment lawsuit against Corcept Therapeutics. The court denied Teva's motion to compel production of text messages from Corcept's DOJ production, finding Teva failed to show the messages were relevant or proportional. This is a minor procedural setback in a pending case, no damages, no injunction, no change to the underlying claims.

Court Ruling Details

Ruling Date
Jul 23, 2026
Court
United States District Court for the Northern District of California
Court Level
District
Judge
Virginia K. DeMarchi
Case Type
antitrust
Ruling Type
discovery
Outcome
LOSS: ruling against this company
Precedent Risk
LOW

Key Facts

  • Teva sued Corcept alleging anticompetitive physician payments to induce prescriptions of Korlym over Teva's generic mifepristone.
  • Teva moved to compel Corcept to produce text messages from a prior DOJ production regarding physician payments.
  • The court denied the motion, ruling Teva did not show the text messages were relevant or proportional to the case.
  • The ruling is a discovery dispute resolution, no damages awarded, no injunction issued, no claims dismissed.
  • The case (5:24-cv-03567-NW) remains active in the Northern District of California.

Financial Impact

No financial impact, discovery ruling only, no damages or exposure stated.

Risk Factors

  • Teva's antitrust claims against Corcept remain pending and could result in damages or injunctive relief if Teva ultimately prevails.
  • Corcept's motion practice may delay resolution of the case, extending legal costs and uncertainty.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-dec579e875-TEVA

Track record

61 reports on TEVA

Performance horizon

6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
  2. Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
  5. Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
  6. Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  7. Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  9. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
  10. Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
Showing 10 of 61

US Market Status

Market Closed · Opens in 8h 16m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Jul 24, 2026